TNDM


Tandem Diabetes Surpasses 4Q Estimates; Shares Rise 4%

Tandem Diabetes Care delivered a stronger-than-expected 4Q performance, driven by a 67% jump in its global pump shipments. Shares of the insulin delivery …

Tandem Diabetes (TNDM) Draws a Price Target Lift from Oppenheimer on International Launch Potential

Oppenheimer’s Steven Lichtman now bets on 6% in return potential for TNDM stock, with eyes on a new driver: a forthcoming international launch.

Tandem Diabetes Care Inc (TNDM) Strong First Quarter Revenue Growth Sends Shares on a Tear

Tandem Diabetes Care Inc (NASDAQ:TNDM) hit a preliminary home run with its first quarter earnings show for 2018, releasing an exciting revenue beat …

Tandem Diabetes Care Inc (TNDM) Moves the Needle

Investors are racing to buy Tandem Diabetes Care Inc (NASDAQ:TNDM) shares, after the insulin pump maker announced FDA approval and commercial launch of the t:slim …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts